1. Home
  2. Events
  3. ISSCR 2022: How do you SCIENCE?

ISSCR 2022: How do you SCIENCE?

Axol Team

We’re Excited to be Back! Booth #440

Axol are looking forward to being back at ISSCR, both in-person at booth 440 and online.

We’d love to know WHY you SCIENCE with stem cells? What’s your motivation? Why do you use them in your R&D?

At Axol, we ❤️ human induced pluripotent stem cells (hiPSCs). We’re on a mission to provide research scientists with robust, quality-manufactured cells they can rely on for their assays and development of life-changing therapies for the benefit of humankind.

This is WHY WE SCIENCE with hiPSCs.

Our team will be at ISSCR 2022 to discuss all things iPSCs. If you want to ask questions about our latest protocols, or find out what’s on our road map for 2023, swing by for a chat with our experts.

We’re especially interested to learn how you’re innovating in this space. WHY do you SCIENCE with human cells? Or even, HOW do you SCIENCE with human iPSCs? 

How we SCIENCE at Axol Bio

At Axol, our HOW is ‘with quality manufacturing processes.’ Our ISO 9001 accredited manufacturing facility has stringent quality control mechanisms in place to ensure our cells and media are consistent and reliable tools for R&D scientists.

All of our cell products undergo a minimum of seven quality control tests before they are released for sale. And, our cell media undergo a minimum of five tests to ensure they meet our stringent quality criteria, including sterility and consistency checks.

Meet the Team

In attendance:

  • Liam Taylor, CEO
  • Dr Jamie Bhagwan, Group Leader
  • Dr Amaia Paredes-Redondo, Senior Scientist
  • Dr Sapna Vyas, Project Manager
  • Dr Nick Saites, Technical Account Manager
  • Pat McHenry, Global Head of Sales
  • Rachel Jean-Pierre, Digital and Creative Marketing Manager
  • Madison Bodnar, Inside Sales and Customer Experience Specialist

Date: Wednesday June 15 – Saturday June 18, 2022 Time: All day Where: Moscone Convention Center, San Francisco, US Meet the team to learn: -More about why and how we SCIENCE with human iPSCs at Axol -How our new CiPA-validated cardiomyocytes are transforming drug discovery -How motor neuron Maturation Accelerator supplement produces assay-ready iPSC-derived motor neurons in under 3 weeks!

Press enquiries

Dr. Adam Tozer

Axol Bioscience

T: +44 (0) 7398 017191

E: adam.tozer@axolbio.com

W: axolbio.com

NOTES TO EDITOR

About Axol Bioscience

Axol is a leading provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. Our custom research capabilities in gene editing, electrophysiology, reprogramming, and differentiation means we can offer customers validated ready-to-use cell lines and a suite of services bolstered by deep scientific expertise and robust functional data – all with shorter lead times. To find out more, visit axolbio.com.

Share this post:

Related Posts

Previous
Bioengineering the Human Neuromuscular Junction (NMJ)
Next
On Demand: The Use of Human iPSC-Derived Cells in Disease Modeling